Hemgenix
Hemgenix ingredients
| Active ingredient | Strength |
|---|---|
| Etranacogene dezaparvovec | see label |
What Hemgenix is used for
The FDA lists the approved uses on the official label (below). In the EU, etranacogene dezaparvovec is approved as Hemgenix for:
Treatment of severe and moderately severe Haemophilia B (congenital Factor IX deficiency) in adult patients without a history of Factor IX inhibitors.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Hemgenix
- Generic name
- Etranacogene dezaparvovec
- Made by
- CSL Behring
- Forms
- Kit
- FDA approval
- Biologic licence (BLA) BLA125772
- On the US market since
- 2022
Official information
- Hemgenix prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Etranacogene dezaparvovec)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Hemgenix?
Hemgenix (Etranacogene dezaparvovec) is a specialist medicine made by CSL Behring, approved by the US FDA.
What are the ingredients of Hemgenix?
Hemgenix contains Etranacogene dezaparvovec.
Is Hemgenix approved in Europe?
The same active substance is approved in the EU as Hemgenix.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA